Products
Latest Partnered Companies
Projects
Estimated Cost :
US$715 million
Merck Invests US$715 million in New Facility at Madison,USA
Merck with an investment of US$715 million plans for the expansion of Antibody-drug Conjugates (ADC) manufacturing. The new manufacturing facility wil...
Estimated Cost :
$10 million
SCA Pharma Invests $10 million to Build a New Production Facility in Little Rock
SCA Pharma announced its plans to expand operations with the construction of a new production facility in Little Rock
Estimated Cost :
$19 million
Summit Biosciences to invest $19 million in it's production at Lexington, Kentucky
Summit Biosciences Inc., a pharmaceutical company focused on nasal spray medicines, is expanding its operation at the University of Kentucky Coldstrea...
Estimated Cost :
€25 million
Evonik Expands Dossenheim and Hanau Sites in Germany
Evonik has announced plans for the expansion of its Dossenheim and Hanau facilities in Germany in order to meet the increasing pharmaceutical demand f...
Press Release
Janssen Announces U.S. FDA Approval of CABENUVA (rilpivirine and cabotegravir), the First Long-Acting Regimen for the Treatment of HIV
The Janssen Pharmaceutical Companies of Johnson & Johnson announced the U.S. Food and Drug Administration (FDA) has approved CABENUVA (consisting of Janssen's rilpivirine and ViiV Healthcare's cabotegravir),
Bio-Thera Solutions Announces Initiation of Phase I Clinical Trial for BAT1308, a Monoclonal Antibody Targeting PD-1
Bio-Thera Solutions, Ltd., a commercial-stage pharmaceutical company, today announced that dosing has begun in a Phase I clinical study to compare the pharmacokinetics and safety of BAT1308, a monoclonal antibody targeting PD-1 in cancer patient volunteers.
EXACT Therapeutics Announces Innovative Probe Development Collaboration With GE Healthcare
EXACT THERAPEUTICS AS ("EXACT-Tx" or the "Company"), a clinical stage precision medicine company announced a collaboration with GE Healthcare to develop an innovative ultrasound probe to be used in forthcoming studies using Acoustic Cluster Therapy (ACT®) across multiple disease conditions.
Turnstone Biologics Acquires Novel Cell Therapy Platform
Turnstone Biologics Corp., a clinical-stage biotechnology company pioneering the development of cancer immunotherapies, announced that it has acquired California-based Myst Therapeutics, a privately held biotechnology company focused on advancing novel T-cell therapies for solid tumors.
Events
Articles
Nanotechnology in Drug Delivery to Eyes, Skin, and Wounds Via Topical Route
One of the most favored courses for administering medications to eyes, skin, and wounds is the topical route. The principle objective for this
An Overview - Active Pharmaceutical Ingredient (API)
Active Pharmaceutical Ingredient (API) is the term used to refer to the biologically active component of a drug product
Next-Generation Biological Therapeutics Discovery & Development
Next-Generation Biological Therapeutics Discovery & Development
AI, Big Data to Have \'Greatest Technology Impact\' in Pharma Industry in 2019
AI, Big Data to Have \'Greatest Technology Impact\' in Pharma Industry in 2019
Dividella’s Monomaterial Packaging Solution to the Global Plastics Crisis
Dividella’s Monomaterial Packaging Solution to the Global Plastics Crisis
Expert Talk
Testimonials
I have read it with interest. I think it could be of interest to managers and professionals in Asia's Pharma companies as well as global companies that wish to learn more about how to do business--from R&D to marketing-in Asia.
Baoping Wang - Research Director
Novo Nordisk (China) R&D Centre
Advertisements
See your banner here...
